{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:42:06Z","timestamp":1792226526295,"version":"4.4.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04839-6","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:06:07Z","timestamp":1792224367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Periconceptional and early-pregnancy exposure to SGLT2 inhibitors and congenital malformations: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"91","author":[{"given":"Deep","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Sugandha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5681-6522","authenticated-orcid":false,"given":"A. B.M.","family":"Kamrul-Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"issue":"7","key":"4839_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S2213-8587(24)00102-5","volume":"12","author":"MS Usman","year":"2024","unstructured":"M.S. Usman, D.L. Bhatt, I. Hameed, S.D. Anker, A.Y.Y. Cheng, A.F. Hernandez et al., Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 12(7), 447\u2013461 (2024). https:\/\/doi.org\/10.1016\/S2213-8587(24)00102-5","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"Suppl 1","key":"4839_CR2","doi-asserted-by":"publisher","first-page":"S246","DOI":"10.2337\/dc26-S011","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026. Diabetes Care, 2026;49(Suppl 1):S246-S260. https:\/\/doi.org\/10.2337\/dc26-S011","journal-title":"Diabetes Care"},{"issue":"9","key":"4839_CR3","doi-asserted-by":"publisher","first-page":"e1152","DOI":"10.1016\/S2214-109X(20)30315-6","volume":"8","author":"J Bearak","year":"2020","unstructured":"J. Bearak, A. Popinchalk, B. Ganatra, A.B. Moller, \u00d6. Tun\u00e7alp, C. Beavin et al., Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990\u20132019. Lancet Glob Health. 8(9), e1152\u2013e1161 (2020). https:\/\/doi.org\/10.1016\/S2214-109X(20)30315-6","journal-title":"Lancet Glob Health"},{"issue":"Suppl 1","key":"4839_CR4","doi-asserted-by":"publisher","first-page":"S321","DOI":"10.2337\/dc26-S015","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes. 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2026. Diabetes Care, 2026;49(Suppl 1):S321-S338. https:\/\/doi.org\/10.2337\/dc26-S015","journal-title":"Diabetes Care"},{"key":"4839_CR5","doi-asserted-by":"publisher","first-page":"1215356","DOI":"10.3389\/fendo.2023.1215356","volume":"14","author":"DRP Muller","year":"2023","unstructured":"D.R.P. Muller, D.J. Stenvers, A. Malekzadeh, F. Holleman, R.C. Painter, S.E. Siegelaar, Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence. Front. Endocrinol. (Lausanne). 14, 1215356 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1215356","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"4839_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/jamainternmed.2023.6663","volume":"184","author":"CE Cesta","year":"2024","unstructured":"C.E. Cesta, R. Rotem, B.T. Bateman, G. Chodick, J.M. Cohen, K. Furu et al., Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy. JAMA Intern. Med. 184(2), 144\u2013152 (2024). https:\/\/doi.org\/10.1001\/jamainternmed.2023.6663","journal-title":"JAMA Intern. Med."},{"issue":"5","key":"4839_CR7","doi-asserted-by":"publisher","first-page":"104572","DOI":"10.1016\/j.numecd.2026.104572","volume":"36","author":"M Jang","year":"2026","unstructured":"M. Jang, M. Kim, H.S. Suh, Sodium glucose transporter 2 inhibitor exposure and the risk of congenital malformations: nationwide birth cohort study. Nutr. Metab. Cardiovasc. Dis. 36(5), 104572 (2026). https:\/\/doi.org\/10.1016\/j.numecd.2026.104572","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"4839_CR8","doi-asserted-by":"publisher","first-page":"110946","DOI":"10.1016\/j.diabres.2023.110946","volume":"205","author":"JG Ray","year":"2023","unstructured":"J.G. Ray, Z. Harel, R.E. Gilbert, R. Wald, H. Berger, A.L. Park, Preconception SGLT2 or DPP4 inhibitor use and adverse pregnancy outcomes. Diabetes Res. Clin. Pract. 205, 110946 (2023). https:\/\/doi.org\/10.1016\/j.diabres.2023.110946","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"8","key":"4839_CR9","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1080\/14767058.2017.1402880","volume":"32","author":"NB Eriksen","year":"2019","unstructured":"N.B. Eriksen, P. Damm, E.R. Mathiesen, L. Ringholm, The prevalence of congenital malformations is still higher in pregnant women with pregestational diabetes despite near-normal HbA1c: a literature review. J. Matern Fetal Neonatal Med. 32(8), 1225\u20131229 (2019). https:\/\/doi.org\/10.1080\/14767058.2017.1402880","journal-title":"J. Matern Fetal Neonatal Med."},{"key":"4839_CR10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow et al., The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372, n71 (2021). https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"4839_CR11","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"J.A. Sterne, M.A. Hern\u00e1n, B.C. Reeves, J. Savovi\u0107, N.D. Berkman, M. Viswanathan et al., ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 355, i4919 (2016). https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ"},{"issue":"7650","key":"4839_CR12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"G.H. Guyatt, A.D. Oxman, G.E. Vist, R. Kunz, Y. Falck-Ytter, P. Alonso-Coello, GRADE Working Group et al., GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 336(7650), 924\u2013926 (2008). https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD","journal-title":"BMJ"},{"issue":"6","key":"4839_CR13","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.4093\/dmj.2024.0521","volume":"49","author":"C Su","year":"2025","unstructured":"C. Su, X. He, X. Chang, J. Tian, G. Wang, J. Liu, Novel Insights into the Causal Relationship between Antidiabetic Drugs and Adverse Perinatal Outcomes: A Mendelian Randomization Study. Diabetes Metab. J. 49(6), 1242\u20131251 (2025). https:\/\/doi.org\/10.4093\/dmj.2024.0521","journal-title":"Diabetes Metab. J."},{"issue":"1","key":"4839_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13098-024-01376-y","volume":"16","author":"MAA Campos","year":"2024","unstructured":"M.A.A. Campos, M.L.R. Oppermann, M.T.V. Sanseverino, G.L. Guerra, V.N. Hirakata, A.J. Reichelt, Congenital anomalies in pregnancies with overt and pregestational type 2 diabetes: a gray portrayal from a cohort in Brazil. Diabetol. Metab. Syndr. 16(1), 157 (2024). https:\/\/doi.org\/10.1186\/s13098-024-01376-y","journal-title":"Diabetol. Metab. Syndr."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04839-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04839-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04839-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:06:08Z","timestamp":1792224368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04839-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4839"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04839-6","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"14 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"349"}}